Pharmacovigilance data
Broadening access to signal is a positive step, but access to VigiBase is also needed
read (161 KB)
ISDB General Assembly Meeting - 2012
for members only
Campaigns - Pharmaceutical package
Revised proposals on "information" to patients: still an open door to advertising of prescription-only medicines
Direct-to-consumer "information" on prescription medicines by manufacturers exposes citizens to misleading messages, puts public health at risk and threatens Member State's social protection systems.
read (180 KB)
Latest Campaigns
-
EU Parliament says no and no again to EMA:...
May 15th 2012 - Conflict of interest
-
ISDB General Assembly Meeting - 2012
January 20th 2012 - Support to bulletins
-
Pharmacovigilance in Europe. Signal detection...
November 2nd 2011 - Conflict of interest
Answer to the consultation on the "Concept paper on pharmacovigilance implementing measures"
-
Revised proposals on "information" to...
October 21st 2011 - Pharmaceutical package
Direct-to-consumer "information" on prescription medicines by manufacturers exposes citizens to misleading messages, puts...
-
Open letter to Brown University re journal...
October 4th 2011 - Conflict of interest
ISDB - International Society of Drug bullettins
Contact details:
President: president@isdbweb.org
Webmaster: maria.font@ulss20.verona.it© 2012